Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Lucid Diagnostics Inc. (LUCD) AI Forecast

Our AI analyzed Lucid Diagnostics Inc.. Create a free account and follow it to see the 90-day price prediction.

Free account • 30-day free trial

$LUCD Neutral Signal Full forecast available

Lucid Diagnostics Inc. (LUCD) Stock Forecast 2025


Lucid Diagnostics Inc. (LUCD) AI Stock Price Forecast & Investment Analysis

Lucid Diagnostics Inc. Stock Price Chart and Technical Analysis

Loading chart...

Lucid Diagnostics Inc. (LUCD) - Comprehensive Stock Analysis & Investment Research

Deep dive into Lucid Diagnostics Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 28, 2026, 8:28 a.m. (UTC)

Lucid Diagnostics Inc. Investment Summary

When evaluating whether Lucid Diagnostics Inc. (LUCD) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Lucid Diagnostics Inc. (LUCD) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $172 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Lucid Diagnostics Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Lucid Diagnostics Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Lucid Diagnostics Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Lucid Diagnostics Inc.

Sign Up Free
Corporate Identity

Lucid Diagnostics Inc. (Stock Symbol: LUCD) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Lucid Diagnostics Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Lucid Diagnostics Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Lucid Diagnostics Inc....

Unlock Full Company Profile

Get complete details about Lucid Diagnostics Inc.

Sign Up Free
Revenue & Growth Analysis

Lucid Diagnostics Inc. generates annual revenues of $5 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Lucid Diagnostics Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Lucid Diagnostics Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Lucid Diagnostics Inc....

Unlock Financial Analysis

Get complete financial metrics for Lucid Diagnostics Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Lucid Diagnostics Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Lucid Diagnostics Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Lucid Diagnostics Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-50 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a 27.9% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.

Operating margin of -8089.3% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 0.15x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Current ratio of 1.07 suggests tight liquidity where current assets just cover current liabilities. This may be efficient but leaves limited cushion for unexpected needs.

Lucid Diagnostics Inc. (LUCD) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Lucid Diagnostics Inc. stock analysis.

Deep dive into Lucid Diagnostics Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Lucid Diagnostics Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Lucid Diagnostics Inc.:

P/B Ratio 43.07x
Market Cap $172M
Book Value/Share $0.02
Revenue/Share $0.03
FCF/Share $-0.26
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Lucid Diagnostics Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Lucid Diagnostics Inc.: An ROE of -1677.2% indicates room for improvement in shareholder value creation.

ROE -1677.2%
ROA -196.9%
ROIC -1378.4%
Gross Margin 27.9%
Operating Margin -8089.3%
Net Margin -8386.2%
EBT Margin -8386.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Lucid Diagnostics Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Lucid Diagnostics Inc.: A current ratio of 1.07 shows adequate liquidity.

Current Ratio 1.07x
Quick Ratio 1.05x
D/E Ratio 7.52x
Financial Leverage 8.52x
Interest Coverage -5879.5x
Working Capital $2M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Lucid Diagnostics Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Lucid Diagnostics Inc.: Free cash flow of $-50M indicates cash challenges that need attention.

Operating Cash Flow -$31M
Free Cash Flow -$50M
Capital Spending -$19M
FCF/Sales -977.4%
CapEx/Sales 370.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Lucid Diagnostics Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Lucid Diagnostics Inc.: An asset turnover of 0.15x suggests room for improvement in asset utilization.

Asset Turnover 0.15x
Receivables Turnover 7.5x
Inventory Turnover 1.2x
Fixed Assets Turnover 5.7x
Days Sales Outstanding 49 days
Days Inventory 297 days
Payables Period 681 days
Cash Conversion Cycle -336 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Lucid Diagnostics Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Lucid Diagnostics Inc.: With annual revenue of $5M, Lucid Diagnostics Inc. represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $5M
Operating Income -$64M
Net Income -$67M
R&D Expense $23M
SG&A Expense $80K
Cost of Goods Sold $580K
Balance Sheet Highlights (% Of Assets)
Total Current Assets 31%
Cash & Short-term Investments 28%
Total Liabilities 30%
Short-term Debt 28%
Accounts Receivable 1%
Inventory 0%
Dividend & Shareholder Information
Shares Outstanding 191M
Growth Metrics (YoY)
Net Income Growth -8386.2%

Latest Lucid Diagnostics Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Lucid Diagnostics Inc. (LUCD) stock price and investment outlook.

📰 Loading...

Lucid Diagnostics Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Lucid Diagnostics Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM ██% $11M x 1.9x
AEMD ██% $1M x 0.3x
ALUR ██% $6M x x
AMIX ██% $2M x 0.3x
ANGO ██% $570M x 3.3x
ANIK ██% $201M x 1.5x
AORT ██% $1.25B 107.3x 2.8x
APYX ██% $163M x 12.7x
ARAY ██% $27M x 0.6x
ATEC ██% $1.33B x x
ATRC ██% $1.90B 182.0x 3.7x
AURX ██% $49M x x
BAX ██% $12.02B x 2.0x
BBNX ██% $713M x 2.6x
BDX ██% $43.79B 38.5x 1.8x
BEAT ██% $29M x 45.9x
BJDX ██% $1M x 0.3x
BSX ██% $67.58B 19.0x 2.6x
BTCY ██% $2M x x
BVS ██% $838M 29.4x 4.4x
BWAY ██% $632M x x
CARL ██% $311M x 3.4x
CERS ██% $596M x 8.8x
CLPT ██% $438M x 23.2x
CODX ██% $7M x 0.5x
CTSO ██% $23M x 10.3x
CVRX ██% $129M x 4.4x
DCTH ██% $412M 733.5x 3.7x
DRIO ██% $55M x 0.9x
DRTS ██% $1.07B x 13.9x
DXCM ██% $28.31B 30.4x 9.6x
EBRCZ ██% $137M x 14.4x
EMBC ██% $204M 1.8x x
FEMY ██% $9M x 1.3x
FOFA ██% $27M 173.9x 28.2x
GCTK ██% $2M x x
GIPL ██% $170K x 0.3x
GKOS ██% $8.87B x 13.2x
GMED ██% $10.59B 18.1x 2.2x
GUTS ██% $127M x 6.0x
HAE ██% $3.62B 37.2x 4.5x
HRGN ██% $18M x 200.7x
HTFL ██% $2.18B x 7.7x
IART ██% $1.50B x 1.4x
ICCM ██% $10M x 1.1x
ICUI ██% $4.04B 87.1x 1.9x
IDXG ██% $43M 1.8x 1.9x
INBS ██% $4M x 0.5x
INSP ██% $1.47B 11.2x 1.9x
IRMD ██% $1.22B 51.5x 12.3x
IRTC ██% $3.68B x 22.9x
IVF ██% $2M x 0.1x
KIDS ██% $469M x 1.4x
KMTS ██% $1.33B x 5.1x
KRMD ██% $188M x 11.1x
LMAT ██% $2.26B 36.2x 5.6x
LNSR ██% $65M 2.2x 6.0x
LUCD ██% $172M x 43.1x
LUNG ██% $52M x 1.1x
LYRA ██% $920K x x
MBOT ██% $118M x 1.6x
MCAG ██% $37M x x
MDAI ██% $52M x x
MDLN ██% $70.74B 84.5x 6.3x
MDNC ██% $59M 65.1x 10.0x
MDXG ██% $634M 20.7x 2.6x
MMED ██% $4.59B x 1.3x
MMM ██% $87.46B 29.2x 29.6x
MMSI ██% $4.54B 32.6x 2.8x
MODD ██% $12M x 1.0x
NEPH ██% $41M 52.7x 3.8x
NMTC ██% $16M x 3.1x
NPCE ██% $498M x 34.4x
NSPR ██% $32M x 0.7x
NUMD ██% $2M x x
NVCR ██% $2.32B x 6.9x
NVNO ██% $7M x 0.3x
NXGL ██% $4M x 1.0x
NYXH ██% $147M x x
OBIO ██% $213M x 5.2x
ODYY ██% $710K x x
OFIX ██% $443M x 1.0x
OSRH ██% $15M x 0.1x
OSUR ██% $280M x 0.9x
PAVM ██% $32M x 0.8x
PDEX ██% $175M 14.6x 3.9x
PEN ██% $12.49B 73.0x 8.5x
PETV ██% $25M x 11.4x
PFSA ██% $930K x x
PLRZ ██% $29M x 1.1x
PLSE ██% $2.11B x 31.9x
PMI ██% $9M x 2.4x
PODD ██% $11.08B 36.6x 8.5x
PRCT ██% $999M x 2.9x
PREM ██% $2M x 0.6x
PROF ██% $249M x 4.2x
PSTV ██% $26M x 2.2x
PYPD ██% $77M x 7.0x
QTEX ██% $49M x 21.3x
RCEL ██% $142M x x
RDGL ██% $29M x 10.7x
RMD ██% $27.83B 18.3x 4.3x
RTGN ██% $75M x x
RVP ██% $20M x 0.3x
SGHT ██% $254M x 4.7x
SGP ██% $698M x 2.8x
SIBN ██% $728M x 4.1x
SIGY ██% $160K x x
SINT ██% $9M x 10.2x
SKIN ██% $95M x 1.7x
SNOA ██% $6M x 1.8x
SNWV ██% $51M 3.2x 27.7x
SOLV ██% $13.85B 9.7x 2.8x
SRTS ██% $50M x 1.1x
SSII ██% $681M x 12.5x
SSKN ██% $0.00M x 0.0x
STIM ██% $121M x 9.1x
STME ██% $6M x x
STVN ██% $5.45B x x
SYK ██% $129.82B 38.9x 5.7x
TCMD ██% $635M 31.3x 2.9x
TELA ██% $27M x x
TFX ██% $5.91B x 1.9x
TLSI ██% $267M x 20.8x
TMCI ██% $258M x 3.4x
TNDM ██% $1.15B x 8.7x
TNON ██% $3M x 1.7x
UFPT ██% $1.89B 27.5x 4.3x
USAQ ██% $5M 10.4x 3.0x
UTMD ██% $217M 20.0x 1.8x
VTAK ██% $1M x 0.1x
VVOS ██% $6M x x
VYCO ██% $2M x x
WST ██% $23.20B 41.1x 7.8x
XAIR ██% $4M x 0.6x
XTNT ██% $60M 33.0x 1.2x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Lucid Diagnostics Inc. Stock Forecast

How accurate are Lucid Diagnostics Inc. stock predictions?

Our AI model shows a 37% Spearman correlation coefficient for LUCD predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Lucid Diagnostics Inc. stock price forecasts?

Our analysis considers Lucid Diagnostics Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Lucid Diagnostics Inc. a good investment in 2025?

Based on our AI analysis, Lucid Diagnostics Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Lucid Diagnostics Inc. forecasts updated?

Lucid Diagnostics Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Lucid Diagnostics Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...